Xtx Topco LTD Hille Vax, Inc. Transaction History
Xtx Topco LTD
- $1.72 Billion
- Q3 2025
A detailed history of Xtx Topco LTD transactions in Hille Vax, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 179,184 shares of HLVX stock, worth $374,494. This represents 0.02% of its overall portfolio holdings.
Number of Shares
179,184
Previous 42,753
319.11%
Holding current value
$374,494
Previous $85,000
340.0%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HLVX
# of Institutions
7Shares Held
4.16MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.09MShares$4.37 Million0.0% of portfolio
-
Abingworth LLP London, X01.84MShares$3.84 Million10.2% of portfolio
-
Tekla Capital Management LLC27KShares$56,4290.02% of portfolio
-
Credit Suisse Ag Zurich, V815.7KShares$32,7870.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ10.9KShares$22,6910.01% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $69.9M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.